The immunoglobulin A1 proteinase from Streptococcus pneumoniae is inhibited by tetracycline compounds

FEMS Immunology and Medical Microbiology

Volumn 48, Issue 2, 2006, Pages 218-222

  Walker, Stephen G ^a   Carnu, Oana I ^a   Tüter, Gülay ^b   Ryan, Maria E ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Chemically modified tetracycline; Doxycycline; IgA1 proteinase; Metalloproteinase; Streptococcus pneumoniae

Indexed keywords

DOXYCYCLINE; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN A1 PROTEINASE; PROTEINASE; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL VIRULENCE; BACTERIUM CULTURE; ENZYME INHIBITION; ENZYME ISOLATION; GEL MOBILITY SHIFT ASSAY; IC 50; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

DOSE-RESPONSE RELATIONSHIP, DRUG; DOXYCYCLINE; HUMANS; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS; STREPTOCOCCUS PNEUMONIAE; TETRACYCLINES;

EID: 33750067651     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2006.00148.x     Document Type: Article

References (26)

1. Anonymous (2003) Pneumococcal vaccines. Wkly Epidemiol Rec 78: 110-119.
2. Anonymous (1997) Prevention of pneumonococcal disease: recommendations of the advisory committee on immunization practices (ACIP). Morb Mortal Wkly Rep 46: 1-24.
3. Auld DS (1995) Removal and replacement of metal ions in metallopeptidases. Methods Enzymol 248: 228-242.
4. Bernatoniene J & Finn A (2005) Advances in pneumococcal vaccines: advantages for infants and children. Drugs 65: 229-255.
5. Bogaert D, de Groot R & Hermans PWM (2004) Streptococcus pneumoniae colonization: the key to pneumococcal disease. Lancet Infect Dis 4: 144-154.
6. Bradley SF (2005) Double, double, toil and trouble: infections still spreading in long-term-care facilities. Infect Control Hosp Epidemiol 26: 227-230.
7. Byington CL, Samore MH, Stoddard GJ et al. (2005) Temporal trends in invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis 41: 21-29.
8. Carter RJ, Sorenson G, Heffernan R, Kiehlbauch JA, Kornblum JS, Leggiadro RJ, Nixon LJ, Wertheim WA, Whitney CG & Layton M (2005) Failure to control an outbreak of multidrug-resistant Streptococcus pneumoniae in a long-term-care facility: emergence and ongoing transmission of a fluoroquinolone-resistant strain. Infect Control Hosp Epidemiol 26: 248-255.
9. Chiavolini D, Memmi G, Maggi T, Lannelli F, Pozzi G & Oggioni MR (2003) The three extra-cellular zinc metalloproteinases of Streptococcus pneumoniae have different impact on virulence in mice. BMC Microbiol 3: 14.
10. Dezube BJ, Krown SE, Lee JY, Bauer KS & Aboulafia DM (2006) Random phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS malignancy consortium study. J Clin Oncology 24: 1389-1394.
11. Fry AM, Udeagu CCN, Soriano-Gabarro M et al. (2005) Persistence of fluoroquinolone-resistant, multidrug-resistant Streptococcus pneumoniae in a long-term-care facility: efforts to reduce intrafacility transmission. Infect Control Hosp Epidemiol 26: 239-247.
12. Golub LM, Ramamurthy NS, McNamara TF, Greenwald RA & Rifkin BR (1991) Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med 2: 297-321.
13. Hava DL & Camilli A (2002) Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol Microbiol 45: 389-1405.
14. Karchmer AW (2004) Increased antibiotic resistance in respiratory tract pathogens: PROTEKT US - an update. Clin Infect Dis 39 (Suppl. 3), S142-S150.
15. Kilian M, Reinholdt J, Lomholt H, Poulsen K & Frandsen EVG (1996) Biological significance of IgA1 proteases in bacterial colonization and pathogenesis: critical evaluation of experimental evidence. APMIS 104: 321-338.
16. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
17. Massova I, Kotra LP, Fridman R & Mobashery S (1998) Matrix metalloproteinases: structures, evolution, and diversification. FASED J 12: 1075-1095.
18. Nelson ML (1998) Chemical and biological dynamics of tetracyclines. Adv Dent Res 12: 5-11.
19. Plaut AG (2004) IgA-specific metalloendopeptidase. Handbook of Proteolytic Enzymes, 2nd edn (Barrett AJ, Rawlings ND & Woessner JF, eds), pp. 772-775. Academic Press, London.
20. Plaut AG & Wright A (1995) Immunoglobulin A-metallo-type specific prolyl endopeptidases. Methods Enzymol 248: 634-642.
21. Polissi A, Pontiggi A, Feger G, Altier M, Mottl H, Ferrari L & Simon D (1998) Large-scale identification of virulence genes from Streptococcus pneumoniae. Infect Immun 66: 5620-5629.
22. Qiu J, Brackee GP & Plaut AG (1996) Analysis of the specificity of bacterial IgA proteases by a comparative study of ape serum IgA as substrates. Infect Immun 64: 933-937.
23. Senior BW & Woof JM (2005) The influences of hinge length and composition of the susceptibility of human IgA to cleavage by diverse bacterial IgA1 proteases. J Immunol 174: 7792-7799.
24. Wani JH, Gilbert JV, Plaut AG & Weiser JN (1996) Identification, cloning, and sequencing of the immunoglobulin A1 protease gene of Streptococcus pneumoniae. Infect Immun 64: 3967-3974.
25. Weiser JN, Bae D, Fasching C, Scamurra RW, Ratner AJ & Janoff EN (2003) Antibody-enhanced pneumococcal adherence requires IgA1 protease. Proc Nat Acad Sci USA 100: 4215-4220.
26. Wilson JJ, Matsushita O, Okabe A & Sakon J (2003) A bacterial collagen-binding domain with novel calcium-binding motif controls domain orientation. EMBO J 22: 1743-1752.